In a statement, the Department of Health and Social Care told the BBC the government "took every possible step to build the largest diagnostic industry in UK history rapidly and from scratch".
data from the first cohort dosed with AVA6000 at 80mg/m2 in the ongoing Phase I trial. Following this review, the SDMC has recommended that the clinical trial continues as planned and escalates to the next dose of AVA6000 at 120mg/m2.
Surely if a low ball offer came forward a bidding war would follow, cant see for example Roche standing idly by and letting merck pick it up for next to nothing.